SARS-CoV-2 (COVID-19) Antigen

SARS-CoV-2 (COVID-19) Antigen Rapid Test

 

- Specimen: Nasopharyngeal Swab or Oropharyngeal Swab

- Fast Reaction: 15 minutes

- Sensitivity(PPA): 95.00% (95% CI: 88.83%-97.85%)

- Specificity(NPA): 99.75% (95% CI: 98.60%-99.96%)

- Total Consistent(OPA): 98.80% (95% CI: 97.41%-99.45%)



  • Introduction
  • Manual
  • Intrusctions

The SARS-CoV-2 Antigen Rapid Test is intended for in vitro qualitative detection of SARS-CoV-2 antigen in human nasopharyngeal swab or oropharyngeal swab samples.It it to be used as an aid in the diagnosis of coronavirus infection disease (COVID-19), which is caused by SARS-CoV-2.


The test provides preliminary test results. Negative results don't preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decision.


COVID-19, it is a novel coronavirus with new strain thathas not been previously identified in humans, belongs to Coronaviruses (CoV) suchas Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV).


Product Name
Specimen
Format
Kit Size

SARS-CoV-2 Antigen

Rapid Test

Nasopharyngeal Swab / Oropharyngeal Swab
Cassette
20 Tests/box





Please contact us for any enquiries.

Email: sales@hightopbio.com


Exclusive Agent for Germany Home-use Test:

德国家庭自检独家代理:


Mr. Michael P. Matzner

Geschäftsführung 

Phone: +43 (0) 664 1517221 





Copyright © HIGHTOP Biotech